Trichomoniasis: Challenges to appropriate management

Clinical Infectious Diseases

Volumn 44, Issue SUPPL. 3, 2007, Pages

  Wendel, Karen A ^a,d   Workowski, Kimberly A ^b,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; FURAZOLIDONE; METRONIDAZOLE; NONOXINOL 9; POVIDONE IODINE; TINIDAZOLE; TRANYLCYPROMINE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DIAGNOSTIC ACCURACY; DIZZINESS; DRUG MEGADOSE; FALSE POSITIVE RESULT; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; LOW BIRTH WEIGHT; MUSCLE CRAMP; MYCOSIS; NAUSEA; NEUTROPENIA; PANCREATITIS; PAPANICOLAOU TEST; PARASITE IDENTIFICATION; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; TASTE DISORDER; THIRST; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINARY FREQUENCY; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINAL PRURITUS; VIRUS TRANSMISSION; VOMITING;

ANIMALS; FEMALE; HUMANS; MALE; PREGNANCY; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 33947386635     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/511425     Document Type: Article

References (66)

1. World Health Organization (WHO). An overview of selected curable sexually transmitted diseases. Global Programme on AIDS Report 1995. Geneva: WHO, 1995.
2. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26(Suppl 4):S2-7.
3. Miller WC, Swygard H, Hobbs MM, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005; 32: 593-8.
4. Hardy PH, Hardy JB, Nell EE, Graham DA, Spence MR, Rosenbaum RC. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984; 2: 333-7.
5. Lawing LF, Hedges SR, Schwebke JR. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 2000; 38:3585-8.
6. Schwebke JR, Hook EW III. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003; 188:465-8.
7. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003; 79:151-3.
8. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997; 24:353-60.
9. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150: 965-72.
10. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
11. Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381-7.
12. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34:519-22.
13. Gardner WA Jr, Culberson DE, Bennett BD. Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 1986; 110:430-2.
14. Krieger JN, Riley DE, Roberts MC, Berger RE. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 1996; 34:3120-8.
15. Kuberski T. Trichomonas vaginalis associated with nongonococcal urethritis and prostatitis. Sex Transm Dis 1980; 7:135-6.
16. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type I. J Infect Dis 2001; 183:1017-22.
17. Gopalkrishnan K, Hinduja IN, Kumar TC. Semen characteristics of asymptomatic males affected by Trichomonas vaginalis. J In Vitro Fert Embryo Transf 1990; 7:165-7.
18. Yap EH, Ho TH, Chan YC, et al. Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med 1995; 71:402-4.
19. Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000; 108:301-8.
20. Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36:3205-10.
21. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002; 35:576-80.
22. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039-44.
23. Briselden AM, Hillier SL. Evaluation of affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol 1994; 32:148-52.
24. DeMeo LR, Draper DL, McGregor JA, et al. Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol 1996; 174:1339-42.
25. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005; 43:684-7.
26. Lara-Torre E, Pinkerton JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear. Am J Obstet Gynecol 2003; 188:354-6.
27. Wood BA, Monro AM. Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Dis 1975; 51: 51-3.
28. Viitanen J, Haataja H, Mannisto PT. Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother 1985; 28:812-4.
29. Mannisto P, Karhunen M, Mattila J, et al. Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration. Infection 1984; 12:197-201.
30. Apte W, Packard RS. Tinidazole in the treatment of trichomoniasis, giardiasis and amoebiasis: report of a multicentre study. Drugs 1978; 15(Suppl 1):43-8.
31. Anjaeyulu R, Gupte SA, Desai DB. Single-dose treatment of trichomonal vaginitis: a comparison of tinidazole and metronidazole. J Int Med Res 1977; 5:438-41.
32. Begum SF, Alid SE, Ali S. Short course nitroimidazole in the treatment of vaginal trichomoniasis. Curr Ther Res 1980; 28:922-6.
33. Bloch B, Smyth E. The treatment of Trichomonas vaginalis vaginitis: an open controlled prospective study comparing a single dose of metronidazole tablets, benzoyl metronidazole suspension and tinidazole tablets. S Afr Med J 1985; 67:455-7.
34. Gabriel G, Robertson E, Thin RN. Single dose treatment of trichomoniasis. J Int Med Res 1982; 10:129-30.
35. Garud M, Lulla M, Saraiya U, Vaidya S. Oral single-dose therapy of trichomonal vaginitis: comparison of tinidazole and metronidazole. J Obstet Gynaecol India 1978; 28:347-50.
36. Manorama HT, Shenoy DR. Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole. J Int Med Res 1978; 6: 46-9.
37. Prasertsawat P, Jetsawangsri T. Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 1992; 19:295-7.
38. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003;(2):CD000218.
39. Lossick JG, Kent HL. Trichomoniasis: trends in diagnosis and management. Am J Obstet Gynecol 1991; 165(4 Pt 2):1217-22.
40. Perez S, Fernandez-Verdugo A, Perez F, Vazquez F. Prevalence of 5-nitroimidazole-resistant Trichomonas vaginalis in Oviedo, Spain. Sex Transm Dis 2001; 28:115-6.
41. Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001; 46:545-9.
42. Lossick JG, Muller M, Gorrell TE. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 1986; 153:948-55.
43. Muller M, Lossick JG, Gorrell TE. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis 1988; 15:17-24.
44. Sobel JD, Nyirjesy P, Brown W Tinidazole therapy for metronidazole- resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33:1341-6.
45. Crowell AL, Sanders-Lewis KA, Secor WE. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 2003; 47:1407-9.
46. Forsgren A, Forssman L. Metronidazole-resistant Trichomonas vaginalis. Br J Vener Dis 1979; 55:351-3.
47. Voolmann T, Boreham P. Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J Aust 1993; 159:490.
48. Lewis DA, Habgood L, White R, Barker KF, Murphy SM. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy. Int J STD AIDS 1997; 8:780-4.
49. Hamed KA, Studemeister AE. Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole: a case report. Sex Transm Dis 1992; 19:339-40.
50. Livengood CH III, Lossick JG. Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9. Obstet Gynecol 1991; 78(5 Pt 2):954-6.
51. Hager WD. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients. Sex Transm Dis 2004; 31:343-5.
52. Dan M, Sobel J. Trichomoniasis as seen in a chronic vaginitis clinic. Infect Dis Obs Gyn 1996; 4:477-84.
53. Kanno M, Sobel JD. Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or re-infection? Sex Transm Infect 2003; 79:260-1.
54. Saurina G, DeMeo L, McCormack WM. Cure of metronidazole- and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole. Clin Infect Dis 1998; 26:1238-9.
55. Nyirjesy P, Weitz MV, Gelone SP, Fekete T. Paromomycin for nitroimidazole-resistant trichomonosis. Lancet 1995; 346:1110.
56. Henderson J, Tait I. The use of povidone-iodine ('Betadine') pessaries in the treatment of candidal and trichomonal vaginitis. Curr Med Res Opin 1975; 3:157-62.
57. Antonelli NM, Diehl SJ, Wright JW. A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis. Am J Obstet Gynecol 2000; 182:1008-10.
58. Narcisi E, Secor W. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 1996; 40:1121-5.
59. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997; 44:179-82.
60. Burtin P, Taddio A, Aribumu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172(2 Pt 1):525-9.
61. Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001;63:186-92.
62. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998; 105:322-7.
63. Morgan I. Metronidazole treatment in pregnancy. Int J Gynaecol Obstet 1978; 15:501-2.
64. Ross SM, van Middelkoop A. Trichomonas infection in pregnancy - does it affect perinatal outcome? S Afr Med J 1983; 63:566-7.
65. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345:487-93.
66. Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003; 189:1398-400.